Evidence map›Paper›PMID 33239290›Full record

ArticleScience advances2020

A matricellular protein fibulin-4 is essential for the activation of lysyl oxidase.

Kazuo Noda, Kaori Kitagawa, Takao Miki, Masahito Horiguchi, Tomoya O Akama, Takako Taniguchi, Hisaaki Taniguchi, Kazuaki Takahashi, Yasumitsu Ogra, Robert P Mecham and 3 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Fibulin-4 and latent-transforming growth factor beta-binding protein-4 interactions with syndecan-2 and syndecan-3 are required for elastogenesis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Protective Role of Endothelial Fibulin-4 in Valvulo-Arterial Integrity.Journal of the American Heart Association · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Kazuo NodaDepartment of Pharmacology, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.ORCID 0000-0002-6024-0888
Kaori KitagawaDepartment of Pharmacology, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.ORCID 0000-0001-7732-3893
Takao MikiDepartment of Pharmacology, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Masahito HoriguchiDepartment of Emergency Medicine, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto 605-0981, Japan.ORCID 0000-0001-5325-3931
Tomoya O AkamaDepartment of Pharmacology, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Takako TaniguchiDivision of Disease Proteomics, Institute for Enzyme Research, Tokushima University, Tokushima 770-8503, Japan.
Hisaaki TaniguchiDivision of Disease Proteomics, Institute for Enzyme Research, Tokushima University, Tokushima 770-8503, Japan.
Kazuaki TakahashiLaboratory of Toxicology and Environmental Health, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.ORCID 0000-0002-5298-6305
Yasumitsu OgraLaboratory of Toxicology and Environmental Health, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.ORCID 0000-0002-8268-1828
Robert P MechamDepartment of Cell Biology and Physiology, Washington University School of Medicine, Saint Louis, MO 63110, USA.ORCID 0000-0002-4020-9277
Masahiko TerajimaDivision of Oral and Craniofacial Health Sciences, Adams School of Dentistry, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0002-1502-7930
Mitsuo YamauchiDivision of Oral and Craniofacial Health Sciences, Adams School of Dentistry, University of North Carolina, Chapel Hill, NC 27599, USA.
Tomoyuki NakamuraDepartment of Pharmacology, Kansai Medical University, Hirakata, Osaka 573-1010, Japan. nakamtom@hirakata.kmu.ac.jp.ORCID 0000-0002-8017-9818
Kansai Medical University · JPChiba University · JPTokushima University · JPUniversity of North Carolina at Chapel Hill · USKyoto first Red Cross hospital · JPWashington University in St. Louis · US

Funding

ASSEMBLY OF LUNG ELASTINR37HL053325 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P. · 2000 to 2009
$4.1M
ASSEMBLY OF LUNG ELASTINR01HL053325 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P. · 1995 to 2019
$3.6M
VESSEL STIFFENING, HYPERTENSION, AND VASCULAR EXTRACELLULAR MATRIXR01HL105314 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P., WAGENSEIL, JESSICA · 2010 to 2018
$3.2M
NHLBI NIH HHS R01 HL053325NHLBI NIH HHS R01 HL105314NHLBI NIH HHS R37 HL053325
6 · The paper itself

Abstract

Fibulin-4 is a matricellular protein required for extracellular matrix (ECM) assembly. Mice deficient in fibulin-4 (

Indexed as

ElastinProtein-Lysine 6-OxidaseAnimalsCollagenCopperExtracellular Matrix ProteinsMiceCollagenCopperElastinExtracellular Matrix Proteinsfibulin-4, mouseProtein-Lysine 6-Oxidase

Identifiers

PMID33239290
PMCPMC7688322
OpenAlexW3110339037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.